Impact of statin treatment and exposure on the risk of chronic allograft dysfunction in Chinese lung transplant recipients

Impact of Pre‐Lung Transplant Statin Use on the Development of Primary Graft Dysfunction

(2023) Valerie Yuenger et al.   PHARMACOTHERAPY

Current state of clinical trials on xenograft

(2023) Jad El Masri et al.   XENOTRANSPLANTATION

Systems prediction of chronic lung allograft dysfunction: Results and perspectives from the Cohort of Lung Transplantation and Systems prediction of Chronic Lung Allograft Dysfunction cohorts

(2023) Christophe Pison et al.   Frontiers in Medicine

Inflammation on bronchoalveolar lavage cytology is associated with decreased chronic lung allograft dysfunction‐free survival

(2022) Nancy Y. Greenland et al.   CLINICAL TRANSPLANTATION

Chronic Lung Allograft Dysfunction

(2022) Aida Venado et al.   Thoracic Surgery Clinics

Statin Use May Be Associated With a Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients

(2022) Armelle Pérez Cortés Villalobos et al.   CLINICAL INFECTIOUS DISEASES

Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience

(2022) Marta Cristeto Porras et al.   CLINICAL TRANSPLANTATION

Current state of clinical trials regarding lung transplant rejection

(2022) Rami Rifi et al.   TRANSPLANT IMMUNOLOGY

Value of Preoperative Use of Statins as a Protective Factor for Severe Graft Dysfunction After Lung Transplantation: A Multicenter Propensity Score Analysis

(2021) Irene Bello et al.   ARCHIVOS DE BRONCONEUMOLOGIA

Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation

(2021) Lorriana E. Leard et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Statins and Inflammation

(2021) Martin Satny et al.   Current Atherosclerosis Reports

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult lung transplantation report — 2021; Focus on recipient characteristics

(2021) Daniel C. Chambers et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature

(2020) Daniel T. Dugger et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Azithromycin prophylaxis after lung transplantation is associated with improved overall survival

(2020) David Li et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT

(2019) Geert M. Verleden et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Regulatory T cells: Possible mediators for the anti-inflammatory action of statins

(2019) Sanaz Keshavarz Shahbaz et al.   PHARMACOLOGICAL RESEARCH

Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction

(2018) Anna Moniodis et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

De NovoDQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation

(2016) Jussi M. Tikkanen et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics

(2016) A. Roux et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prediction of chronic lung allograft dysfunction: a systems medicine challenge

(2014) C. Pison et al.   EUROPEAN RESPIRATORY JOURNAL

Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study

(2011) Geert M. Verleden et al.   TRANSPLANT INTERNATIONAL

Graft-Protective Effects of the HMG-CoA Reductase Inhibitor Pravastatin After Lung Transplantation— A Propensity Score Analysis With 23 Years of Follow-Up

(2011) Yijiang Li et al.   TRANSPLANTATION